デフォルト表紙
市場調査レポート
商品コード
1186660

馬用ヘルスケアの世界市場:現状分析・予測(2022年~2028年)

Equine Healthcare Market: Current Analysis and Forecast (2022-2028)

出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 158 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
馬用ヘルスケアの世界市場:現状分析・予測(2022年~2028年)
出版日: 2022年12月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 158 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の馬用ヘルスケアの市場規模は、2022年~2028年の間の予測期間中に約5%のCAGRを記録すると予測されています。

世界の馬における疾患の蔓延が、馬用ヘルスケアに対する需要を高めています。さらに、馬用ヘルスケア市場は、動物医療費の増加と馬用ヘルスケア製品の進歩によって成長する見通しです。また、COVID-19の流行時には失業率が上昇し、ロックダウンによって世界中で馬の福祉が危機に晒されたことが市場成長を妨げる要因の1つとなっていますが、COVID-19後は状況が改善され、市場は今後数年間で有望な成長を見せる見通しです。

当レポートでは、世界の馬用ヘルスケア市場について調査分析し、セグメント別・地域別の市場洞察、市場力学、市場動向、競合情勢、企業プロファイルなど、体系的な情報を提供しています。

目次

第1章 市場イントロダクション

第2章 調査手法・前提条件

第3章 市場概要

第4章 エグゼクティブサマリー

第5章 馬用ヘルスケア市場に対するCOVID-19の影響

第6章 世界の馬用ヘルスケア市場収益(2020年~2028年)

第7章 市場洞察:製品別

  • 薬剤
  • ワクチン
  • 薬用飼料添加物
  • 診断
  • その他

第8章 市場洞察:用途別

  • 寄生虫対策
  • インフルエンザ
  • 破傷風
  • ウエストナイルウイルス
  • ウマ伝染性貧血
  • 馬ヘルペスウイルス
  • その他の疾患

第9章 市場洞察:流通チャネル別

  • 動物病院・クリニック
  • 薬局・ドラッグストア

第10章 市場洞察:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 馬用ヘルスケア:市場力学

  • 市場促進要因
  • 市場課題
  • 影響分析

第12章 馬用ヘルスケア:市場機会

第13章 馬用ヘルスケア:市場動向・洞察

第14章 需要サイド・供給サイドの分析

  • 需要サイド分析
  • 供給サイド分析

第15章 バリューチェーン分析

第16章 競合シナリオ

  • 競合情勢

第17章 企業プロファイル

  • Merck & Co., Inc
  • Zoetis
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Hallmarq Veterinary Imaging
  • ESAOTE SPA
  • Vetoquinol S.A
  • Thermo Fisher Scientific Inc.
  • Bayer AG
  • Elanco

第18章 免責事項

目次
Product Code: UMME211472

The equine healthcare market is expected to register a CAGR of approx. 5% over the period of 2022-2028. Equine health is an important aspect of a horse's overall well-being. Maintaining racehorse health is critical because proper management can reduce the occurrence of many disease conditions. As horses interact with their surroundings, they rely on health concerns to maintain proper performance and stability. Understanding the health of the horse can aid in its overall well-being. Routine veterinary care for vaccinations, parasite control, dental care; grooming and hoof care; and protection are all part of horse care. The growing demand for equine healthcare can be attributed to the increasing prevalence of the equine disease across the globe. For instance, according to CDC, in 2021, Eastern equine encephalitis virus disease (Neuroinvasive disease) cases rise from 6 in 2018 to 38 in 2019 and also increase deaths from 1 in 2018 to 19 in 2019. Owing to the glaring statistics, the increasing number of horses suffering from diseases is leading to the growing demand for equine healthcare and would contribute to the growth of the market in the forthcoming period as well. Furthermore, the equine healthcare market is anticipated to grow on account of the increase in animal healthcare spending and the rise in the advancement of equine healthcare products. However, one of the major factors which restricted market growth (during the COVID pandemic) is rising unemployment rates, as, the lockdown measures led to equine welfare crisis concerns all over the world. However, the situation has improved post-COVID, and the market is anticipated to show promising growth in the coming years.

Merck & Co., Inc, Zoetis, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Hallmarq Veterinary Imaging, ESAOTE SPA, Vetoquinol S.A, Thermo Fisher Scientific Inc., Bayer AG, Elanco are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report:

"Amongst product, the drug category accounted for the significant share in the market in 2020"

Based on the product, the equine healthcare market is segmented into drugs, vaccines, medicinal feed additives, diagnostics, and others. The drug segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to a surge in awareness toward effective & advanced drugs and vaccines, and a rise in number of cases of equine diseases.

"Amongst application, the parasite control category is expected to witness considerable CAGR during the forecast period"

Based on the application, the market is fragmented into parasite control, influenza, tetanus, west Nile virus, equine infectious anemia, equine herpes virus, and others. The parasite control segment grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. There are numerous ways to administer parasiticides, including sprays, collars, oral solutions, gels, and spot-on treatments. Ectoparasiticides are used to treat external parasites, while endoparasiticides treat internal parasites. They are also suitable for use topically, orally, or intravenously.

"Amongst distribution channel, the veterinary hospitals and clinics category is expected to witness considerable CAGR during the forecast period"

Based on the distribution channel, the market is fragmented into veterinary hospitals and clinics, retail pharmacies, and drug stores. The veterinary hospitals and clinics segment grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. increase in the number of veterinary hospitals, clinics, and veterinarians due to an increase in equine diseases and the equine population is likely to aid the segment growth.

"North America to witness significant growth during the forecast period"

For a better understanding of the market dynamics of the equine healthcare market, a detailed analysis was conducted for different regions across the globe including North America (the U.S, Canada, and the Rest of North America), Europe (Germany, France, Spain, United Kingdom, Italy, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America constitutes a major market for the equine healthcare industry owing to the ease of availability of the products and services across developing countries, the rise in animal health expenditure, and the increase in the population of equine. For instance, according to the FAO, there were around 10.56 million horses in the U.S. in 2021, and about 10.96 million horses in the North American region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global equine healthcare market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Equine Healthcare Market
  • 2.2. Research Methodology of the Equine Healthcare Market
  • 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE EQUINE HEALTHCARE MARKET

6 GLOBAL EQUINE HEALTHCARE MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT

  • 7.1. Drug
  • 7.2. Vaccines
  • 7.3. Medicinal Feed Additives
  • 7.4. Diagnostics
  • 7.5. Others

8 MARKET INSIGHTS BY APPLICATION

  • 8.1. Parasite Control
  • 8.2. Influenza
  • 8.3. Tetanus
  • 8.4. West Nile Virus
  • 8.5. Equine Infectious Anemia
  • 8.6. Equine Herpes Virus
  • 8.7. Other diseases

9 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

  • 9.1. Veterinary Hospitals and Clinics
  • 9.2. Retail pharmacies and Drug Stores

10 MARKET INSIGHTS BY REGION

  • 10.1 NORTH AMERICA EQUINE HEALTHCARE MARKET
    • 10.1.1
    • 10.1.2
    • 10.1.3
  • 10.2 EUROPE EQUINE HEALTHCARE MARKET
    • 10.2.1
    • 10.2.2
    • 10.2.3
    • 10.2.4
    • 10.2.5
    • 10.2.6
  • 10.3 ASIA PACIFIC EQUINE HEALTHCARE MARKET
    • 10.3.1
    • 10.3.2
    • 10.3.3
    • 10.3.4
    • 10.3.5
  • 10.4 REST OF THE WORLD EQUINE HEALTHCARE MARKET

11 EQUINE HEALTHCARE MARKET DYNAMICS

  • 11.1 Market Drivers
  • 11.2 Market Challenges
  • 11.3 Impact Analysis

12 EQUINE HEALTHCARE MARKET OPPORTUNITIES

13 EQUINE HEALTHCARE MARKET TRENDS & INSIGHTS

14 DEMAND AND SUPPLY SIDE ANALYSIS

  • 14.1 Demand Side Analysis
  • 14.2 Supply Side Analysis

15 VALUE CHAIN ANALYSIS

16 COMPETITIVE SCENARIO

  • 16.1. Competitive Landscape
    • 16.1.1

17 COMPANY PROFILED

  • 17.1. Merck & Co., Inc
  • 17.2. Zoetis
  • 17.3. Boehringer Ingelheim International GmbH
  • 17.4. Ceva Sante Animale
  • 17.5. Hallmarq Veterinary Imaging
  • 17.6. ESAOTE SPA
  • 17.7. Vetoquinol S.A
  • 17.8. Thermo Fisher Scientific Inc.
  • 17.9. Bayer AG
  • 17.10. Elanco

18 DISCLAIMER